Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis

Figure 3 Meta-analysis of virological response in only chronic hepatitis B patients and in chronic hepatitis B with nonalcoholic fatty liver disease patients. A: Virological response in only chronic hepatitis B (CHB) patients and in CHB with nonalcoholic fatty liver disease (NAFLD) patients until 48 wk; B: Virological response in only CHB patients and in CHB with NAFLD patients until 96 wk; C: Subgroup analysis according to the treatment regimens until 48 wk; D: Subgroup analysis according to the treatment regimens until 96 wk.